Literature DB >> 29676462

Malignant melanoma association with systemic lupus erythematosus in a large midwestern U.S. patient population: a retrospective study.

Solomiya Grushchak1, Regine J Mathieu1, Kelsey A Orrell1, Erika L Hagstrom1, Anne E Laumann1, Dennis P West1,2, Beatrice Nardone1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29676462      PMCID： PMC5992043          DOI： 10.1111/ijd.13979

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  8 in total

1.  High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.

Authors:  Lene Dreyer; Mikkel Faurschou; Mette Mogensen; Søren Jacobsen
Journal:  Arthritis Rheum       Date:  2011-10

2.  Cancer risk in systemic lupus: an updated international multi-centre cohort study.

Authors:  Sasha Bernatsky; Rosalind Ramsey-Goldman; Jeremy Labrecque; Lawrence Joseph; Jean-Francois Boivin; Michelle Petri; Asad Zoma; Susan Manzi; Murray B Urowitz; Dafna Gladman; Paul R Fortin; Ellen Ginzler; Edward Yelin; Sang-Cheol Bae; Daniel J Wallace; Steven Edworthy; Soren Jacobsen; Caroline Gordon; Mary Anne Dooley; Christine A Peschken; John G Hanly; Graciela S Alarcón; Ola Nived; Guillermo Ruiz-Irastorza; David Isenberg; Anisur Rahman; Torsten Witte; Cynthia Aranow; Diane L Kamen; Kristjan Steinsson; Anca Askanase; Susan Barr; Lindsey A Criswell; Gunnar Sturfelt; Neha M Patel; Jean-Luc Senécal; Michel Zummer; Janet E Pope; Stephanie Ensworth; Hani El-Gabalawy; Timothy McCarthy; Lene Dreyer; John Sibley; Yvan St Pierre; Ann E Clarke
Journal:  J Autoimmun       Date:  2013-02-12       Impact factor: 7.094

3.  The incidence and prevalence of systemic lupus erythematosus, 2002-2004: The Georgia Lupus Registry.

Authors:  S Sam Lim; A Rana Bayakly; Charles G Helmick; Caroline Gordon; Kirk A Easley; Cristina Drenkard
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

4.  Cumulative immunosuppressant exposure is associated with diversified cancer risk among 14 832 patients with systemic lupus erythematosus: a nested case-control study.

Authors:  Chung-Yuan Hsu; Ming-Shyan Lin; Yu-Jih Su; Tien-Tsai Cheng; Yu-Sheng Lin; Ying-Chou Chen; Wen-Chan Chiu; Tien-Hsing Chen
Journal:  Rheumatology (Oxford)       Date:  2017-04-01       Impact factor: 7.580

5.  Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus.

Authors:  L Mellemkjaer; V Andersen; M S Linet; G Gridley; R Hoover; J H Olsen
Journal:  Arthritis Rheum       Date:  1997-04

6.  The Incidence and Prevalence of Systemic Lupus Erythematosus in New York County (Manhattan), New York: The Manhattan Lupus Surveillance Program.

Authors:  Peter M Izmirly; Isabella Wan; Sara Sahl; Jill P Buyon; H Michael Belmont; Jane E Salmon; Anca Askanase; Joan M Bathon; Laura Geraldino-Pardilla; Yousaf Ali; Ellen M Ginzler; Chaim Putterman; Caroline Gordon; Charles G Helmick; Hilary Parton
Journal:  Arthritis Rheumatol       Date:  2017-09-10       Impact factor: 10.995

7.  Systemic lupus erythematous and malignancy risk: a meta-analysis.

Authors:  Lihong Cao; Hongyan Tong; Gaixiang Xu; Ping Liu; Haitao Meng; Jinghan Wang; Xiaoying Zhao; Yongmin Tang; Jie Jin
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

8.  Association Between Race/Ethnicity and Survival of Melanoma Patients in the United States Over 3 Decades: A Secondary Analysis of SEER Data.

Authors:  Melissa Ward-Peterson; Juan M Acuña; Mohammed K Alkhalifah; Abdulrahman M Nasiri; Elharith S Al-Akeel; Talal M Alkhaldi; Sakhr A Dawari; Sami A Aldaham
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889
  8 in total
  1 in total

Review 1.  STAT3 and STAT5 Targeting for Simultaneous Management of Melanoma and Autoimmune Diseases.

Authors:  Stella Logotheti; Brigitte M Pützer
Journal:  Cancers (Basel)       Date:  2019-09-27       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.